Generalized anxiety disorder (GAD) is a major problem for millions, causing physical pain and social isolation that traditional meds often fail to fix. To solve this, researchers are testing MM120, a pharmaceutical form of LSD. This drug works by boosting neuroplasticity and rewiring negative thought patterns in the brain. The benefit is a massive drop in symptoms—up to five times more effective than standard drugs—helping those with severe anxiety return to work, build relationships, and live much healthier, calmer lives.
